Testing effectiveness (Phase 2)Looking for participantsNCT04644289
What this trial is testing
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
Who this might be right for
Epithelial Ovarian Cancer
AGO Research GmbH 60